"Narrative Summit" Releases 2025 Recommendations to Cement Egypt's Position as a Global Tourism Destination    Egypt, S.Arabia step up trade ties through coordination council talks    Egypt reviews progress on $200m World Bank-funded waste management hub    Egypt urges Israel to accept Gaza deal amid intensifying fighting    Egypt, ADIB explore strategic partnership in digital healthcare, investment    SCZONE, Tokyo Metropolitan Government sign MoU on green hydrogen cooperation    Egypt welcomes international efforts for peace in Ukraine    Al-Sisi, Macron reaffirm strategic partnership, coordinate on Gaza crisis    Contact Reports Strong 1H-2025 on Financing, Insurance Gains    Egypt, India's BDR Group in talks to establish biologics, cancer drug facility    AUC graduates first cohort of film industry business certificate    Egyptian pound down vs. US dollar at Monday's close – CBE    Egypt's FM, Palestinian PM visit Rafah crossing to review Gaza aid    Egypt prepares unified stance ahead of COP30 in Brazil    Egypt recovers collection of ancient artefacts from Netherlands    Egypt harvests 315,000 cubic metres of rainwater in Sinai as part of flash flood protection measures    Egypt, Namibia explore closer pharmaceutical cooperation    Fitch Ratings: ASEAN Islamic finance set to surpass $1t by 2026-end    Renowned Egyptian novelist Sonallah Ibrahim dies at 88    Egyptian, Ugandan Presidents open business forum to boost trade    Al-Sisi says any party thinking Egypt will neglect water rights is 'completely mistaken'    Egypt's Sisi warns against unilateral Nile measures, reaffirms Egypt's water security stance    Egypt's Sisi, Uganda's Museveni discuss boosting ties    Egypt, Huawei explore healthcare digital transformation cooperation    Egypt's Sisi, Sudan's Idris discuss strategic ties, stability    Egypt to inaugurate Grand Egyptian Museum on 1 November    Greco-Roman rock-cut tombs unearthed in Egypt's Aswan    Egypt reveals heritage e-training portal    Sisi launches new support initiative for families of war, terrorism victims    Egypt expands e-ticketing to 110 heritage sites, adds self-service kiosks at Saqqara    Palm Hills Squash Open debuts with 48 international stars, $250,000 prize pool    On Sport to broadcast Pan Arab Golf Championship for Juniors and Ladies in Egypt    Golf Festival in Cairo to mark Arab Golf Federation's 50th anniversary    Germany among EU's priciest labour markets – official data    Paris Olympic gold '24 medals hit record value    A minute of silence for Egyptian sports    Russia says it's in sync with US, China, Pakistan on Taliban    It's a bit frustrating to draw at home: Real Madrid keeper after Villarreal game    Shoukry reviews with Guterres Egypt's efforts to achieve SDGs, promote human rights    Sudan says countries must cooperate on vaccines    Johnson & Johnson: Second shot boosts antibodies and protection against COVID-19    Egypt to tax bloggers, YouTubers    Egypt's FM asserts importance of stability in Libya, holding elections as scheduled    We mustn't lose touch: Muller after Bayern win in Bundesliga    Egypt records 36 new deaths from Covid-19, highest since mid June    Egypt sells $3 bln US-dollar dominated eurobonds    Gamal Hanafy's ceramic exhibition at Gezira Arts Centre is a must go    Italian Institute Director Davide Scalmani presents activities of the Cairo Institute for ITALIANA.IT platform    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



Rights group says ministry gave court false info about drug pricing
Published in Daily News Egypt on 10 - 06 - 2010

CAIRO: The Supreme Administrative Court has adjourned hearing the challenge brought by the government against an April 2010 ruling that froze application of a Ministry of Health decree that radically altered the way medicines are priced.
The Egyptian Initiative for Personal Rights (EIPR) filed a case against decree 373 in October 2009, demanding that it be suspended and eventually abolished. The court of administrative justice ruled in EIPR's favor on April 27, 2010.
During the first appeal hearing held on Monday EIPR says that the Ministry of Health gave the court false information, “claiming that the implementation of the new pricing system had led to price cuts for some 40 pharmaceutical drugs”.
“This contradicts statements from the Minister of Health and other ministry officials that the decree would only apply to drugs registered after the new system goes into effect,” EIPR says in a statement published Thursday.
Kamal Sabra, the assistant minister of health for pharmaceutical affairs, has consistently denied that the decree will be backdated.
In February, the Minister of Health announced that the prices of 40 imported medicines had been reduced under decree 373.
When asked about this by Daily News Egypt Sabra insisted that the price changes of these 40 medicines “has nothing to do with decree 373 and was not taken under its provisions.”
Sabra could not be reached for comment on Monday's hearing.
Decree 373 linked the pricing of both imported innovator brands and generic products to prices in the international market. EIPR says that if implemented the decree will drastically undermine access by Egypt's poor to medicine by significantly raising drug prices.
The pre-existing Cost Plus system priced medicines on the basis of the cost of the raw materials used to produce them.
While the government and drug companies maintain that prices will not increase under the decree, EIPR point to the fact that two drug companies, the Egyptian International Pharmaceutical Industries Company (EIPICO) and the Egyptian Association for Pharmaceutical Producers (EAPP), have petitioned to support the government's appeal as evidence to the contrary.
This development, the NGO suggests, “will indeed lead to higher prices for drugs and more profits for drug companies — a point stressed by EIPR since it first contested the drug pricing decree and confirmed by the lower court's decision”.
The Court of Administrative Justice in April ordered a suspension of decree 373 because, the statement reads, “it willfully ignored ‘the social dimension that the legislator carefully considered' when designing the old pricing system”. The court also held that increased drug prices would be “an inevitable repercussion” of the decree.


Clic here to read the story from its source.